Proactive Investors - Run By Investors For Investors

WideCells taps into 'very interesting' Brazilian cord blood bank market

Stem cells services provider WideCells Group PLC (LON:WDC) has inked two more outlying deals to take it into the rapidly expanding Brazilian cord blood banking market.

Chief executive João Andrade tells Proactive: ''We've been looking at the Brazilian market since we floated back in July last year. We've identified two cord blood banks there that could have the potential to meet our stringent quality criteria for our CellPlan products - the world's first stem cell insurance plan''.

Meet Clinigen Group PLC, Redx Pharma Plc, MaxCyte and Abzena plc at our event, London, 23 March 2017. Register here »
View full WDC profile

WideCells Group Timeline

February 16 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.